Log in


Janusz Jankowski

Office of Research and Innovation
Royal College of Surgeons in Ireland

  • Director (Corporate)/Chief Research & Innovation Officer and Deputy Vice Chancellor
  • Lead for University Research Strategy including trans-disciplinary programmes
  • Lead for University Postgraduate Research Student Programme
  •  Lead for Research Excellence Framework Strategy
  • Lead for University Research Quality
  • Lead for Research Ethics and Governance
  • Chair of University Research Advisory Committee

Research Expertise:
Team Building. Professor Jankowski has a strong track record of building large, successful, multi-disciplinary international Research Teams including the Aspirin Esomerazole Chemoprevention Trial (AspECT), the Chemoprevention Of Pre-malignant Intestinal Neoplasia study (ChOPIN) and the EsophaGEal Gene Consortia (EAGLE). 

Personal Research. His personal Research expertise is in Basic Sciences, Biosciences, Translational Sciences including Genomics Clinical trials, Public Health and Systematic Evidence Based Delphi Reviews.

Specific Expertise. Professor Janusz Jankowski leads one of the most successful clinical cancer prevention programmes in the UK on oesophageal cancer.

Citations. He has an h-index of 60+ with 15,000+ citations (Google Scholar).

Research Biography
Basic Science: "My group elucidated the site and number of stem cells and their progeny in Barrett’s metaplasia (BM) (Gastroenterology 2013). Furthermore we showed that regulation of stem cell plasticity involves nuclear translocation of b-catenin (Am J Pathol 1998 & Gut 2008). Moreover stem cell division may be controlled by mucosal inflammation, especially TNF (Oncogene 2002) and cell adhesion (Lab Invest 1999) (Lab Invest 1998) enabling crypt bifurcation and hence clonal expansion (Gut 2012, Cancer Res 2008 & PNAS 2006)."

Translational and Genomic Science: "We elucidated the epigenetics of the oesophagitis-metaplasia-dysplasia-adenocarcinoma sequence; especially over-expression of the Epidermal Growth Factor Receptor (EGFR) family (Gut 1993) and mutations (Clin Cancer Res 2006). I co-led the application of these findings in large trials addressing EGFR inhibitors in cancer (Lancet Oncology 2014). 

My team reported the first Genome Wide Analysis (GWAS) of BM showing predisposition that could perturb inflammatory regulation via obesity (Nature Genet 2012, Gastroenterology 2015 & Lancet 2016). I have contributed to other GWAS; Multiple Sclerosis (Nature 2011), Colitis (Nature Genet 2009), Psoriasis (Nature Genet 2010), Diabetes (Nature Genet 2011), Spondylitis (Nature Genet 2011) and Stroke (NEJM 2012)."

Clinical Trials and Systematic Reviews: "I set up large intervention trials (BMJ 2010) including the longest prospective randomised chemoprevention trial (AspECT) reporting in 2017. This has influenced the aspirin debate urging caution in primary prevention (Lancet Oncol 2009, Lancet 2009 & Lancet 2011). 

I led research improving Clinical Standards with formal NHS endorsement on cancer surveillance (Am J Gastroenterology 2007 & Gastroenterology 2004) and endoscopic quality (Gastroenterology 2006; & Am J Gastroenterology 2008). I led the largest English-Language Consensus Reviews, BADCAT (Gastroenterology 2012) and BOBCAT (Am J Gastroenterology 2015) (both NHS badged)."

Janusz co-led an international genetic analysis study into oesophageal cancer, read more now.

Education and Mentoring Expertise:
Professor Jankowski is also committed to education and mentoring clinical scientists in designated roles for the British Society Gastroenterology (BSG) and Royal College Physicians as well as many other Non Government Organisations and NHS trusts. 
Past-Chair of BSG Education and Mentoring Committees.


M.B. Ch.B., (with Clinical Merits) University of Glasgow, 1983 
F.R.C.P.E., Clinical Fellow Royal College of Physicians, Edinburgh, 1999
F.R.C.P., Clinical Fellow Royal College of Physicians, London, 2000
Certificate Specialist Register, GI & Medicine General Medical Council , 2867294, Lond, 1997

M.Sc., cum laude, Clinical Trial Research Linacre College, University of Oxford, 2009
M.D., Molecular Medicine Research University of Dundee, 1995
Ph.D., Translational Pathology Research Imperial College, University of London, 1996

F.A.C.G., Fellow Education American College of Gastroenterology, 2007
A.G.A.F., Fellow Education American Gastroenterology Association, 2012
S.F.H.E.A., Senior Fellow Education Higher Education Academy, Plymouth University, 2014
Certificate of Medical Education Madingley Hall, University of Cambridge, 2013
Train the Trainer (Practical Skills) National NHS Endoscopy Centre, 2013

Leadership and Mentoring
Certificates of Mentoring, (Student & Staff) Gerard Egan & Royal Coll Phys, Leicestershire, 2005
Certificate of Leadership, (Team Building) John Adair, University Hospitals, Warwick, 2014
Certificate of Leadership, (Complex Settings) Leadership Foundation Higher Education, London, 2015

Sports and Sports Medicine 
1st Dan Black Belt & Certified Instructor Intern’l TaeKwon-Do Federation, GBR-1-2810, 2015
Certificate of Advanced Life Support Resuscitation Council, UK, 2015
Certificate of Concussion Management American College of Sports Medicine, USA, 2014

Affiliated Societies

International  Interdisciplinary  Everything Esophageal

The International Society for Diseases of the Esophagus is a 501(c)3 non-profit organization.

General Inquiries: info@isde.net
Membership Questions: membership@isde.net

Powered by Wild Apricot Membership Software